Innovative Theranostic Strategy Advances Detection and Treatment of Neuroendocrine Prostate Cancer
A groundbreaking theranostic strategy targeting RET, an emergent biomarker specific to neuroendocrine prostate cancer (NEPC), promises to revolutionize the diagnosis ...

